Clinical evaluation of siddha medicine Vithuvagai chooranam for Aan maladu (Male infertility due to Oligospermia)

Single centric non randomised open clinical trial phase II in “Aan maladu ?(Male infertility due to Oligospermia) with Siddha medicine “Vithuvagai chooranam ? among the patients attending OPD at Government siddha medical college hospital, Chennai - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068164

Enrollment

Registered

2024-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Vithuvagai Chooranam: This Siddha Drug will be given as Oral route 1gm bd dose with milk for 48 days for the management of Aan maladu Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Male infertile Oligospermia Oligoasthenozoospermia Patient willing to give specimen of semen, blood for investigation Patient willing to give consent for the study

Exclusion criteria

Exclusion criteria: Azoospermia Teratospermia Hydrocele Varicocele Diabetes mellitus Klinefelter syndrome Congenital disorders

Design outcomes

Primary

Measure	Time frame
1)Increased sperm count. Severe Oligospermia to Moderate Oligospermia Mild Oligospermia or Normal Moderate Oligospermia to Mild Oligopermia or Normal. Mild Oligospermia to Normal 2)Improved motility function. Immotile to Non progressive motility or Progressive motility. Non progressive motility to Progressive motility.Timepoint: 12 months	—

Secondary

Measure	Time frame
Improvement in General wellbeingTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Anbu N

Government siddha medical college arumbakkam

nanbu.sumi@gmail.com9443279412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026